Precision Nanomedicine

University of Queensland researchers are taking up the fight against one of the deadliest forms of breast cancer, developing next-generation nanoparticles to supercharge current treatments for triple-negative breast cancer.

New international research has its sights set on mosquito-borne neurotropic viruses, like dengue and Japanese Encephalitis, which are a growing global threat, with limited treatment options.

Our body’s complement system is aptly named, given the supporting role it plays in fighting disease and healing injuries.

AIBN researcher Dr Sophia Luikinga is following in the footsteps of her MND research mentor after winning a prestigious fellowship to address the neurodegenerative condition from a new angle.   

It’s smaller than a SIM card, made from gold, and can detect the earliest signs of disease in our blood.

AIBN researchers have won funding to examine if particles in our muscles could unlock new treatments for Motor Neurone Disease.

New nanotechnology from the AIBN labs could help an emerging and non-invasive cancer treatment become even more effective.

Associate Professor Joy Wolfram has won funding to help patients bounce back more effectively after open-heart surgery.

Researchers from the AIBN have made a significant step towards enabling women with epilepsy safer access to a common anti-seizure medication.

Dr Samantha Stehbens says a cell's journey through crowded tissue environments remains shrouded in mystery. In Nature Cell Biology, she may have some new answers.